Table 1.
Clinical characteristic of study participants longitudinally analyzed before and during ART.
| Pre-ART HIV infection stage | AHI (n=14) | Chronic (n=13) | P value |
|---|---|---|---|
| Percentage of male | 100% | 100% | |
| Pre-ART Age (years), median (IQR) | 26 (23-31) | 28 (27·5-33) | 0·07 |
| Pre-ART viral load (copies/mL), median (IQR) | 859,219 (443,546-8,460,425) | 28,962 (9,426-92,155) | <0·0001 |
| Pre-ART CD4 count cells/mm3 in plasma, median (IQR) | 366 (290-425) | 402 (319-505) | 0·28 |
| Pre-ART CD8 count cells/mm3 in plasma, median (IQR) | 592 (315-1202) | 1230 (831-1922) | 0·01 |
| Duration of ART (years), median (IQR) | 1·6 (1·59-1·61) | 1·9 (1·2-2·0) | 0·02 |
| On ART Age (years), median (IQR) | 27 (25-33) | 30 (29-35) | 0·10 |
| On ART CD4 count cells/mm3 in plasma, median (IQR) | 601 (517-785) | 680 (519-784) | 0·79 |
| On ART CD8 count cells/mm3 in plasma, median (IQR) | 736 (499-963) | 988 (569-1154) | 0·05 |
P values from Mann-Whitney are shown.